KEROS THERAPEUTICS
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88949517
- Registration number
- 7502545
- Mark type
- Design + words
- Filed
- 05 Jun 2020
- Published for opposition
- 27 Oct 2020
- Registered
- 10 Sept 2024
- Attorney of record
- Michael J. Belliveau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of hematological disorders
Owner
- Keros Therapeutics, Inc., Lexington, MA, US
- Keros Therapeutics, Inc., Lexington, MA, US
- Keros Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2024 — ASSIGNED TO LIE
- 02 May 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 04 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Nov 2023 — NON-FINAL ACTION E-MAILED
- 04 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 25 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Oct 2023 — USE AMENDMENT FILED